The Journal of Immunology, Vol 156, Issue 11 4318-4327, Copyright © 1996 by American Association of Immunologists

ARTICLES

Presentation of the protective parasite antigen LACK by Leishmania- infected macrophages

E Prina, T Lang, N Glaichenhaus and JC Antoine
Unit of Cellular Immunophysiology, Pasteur Institute, Paris, France.

Macrophages are apparently the only cells that in vivo allow the growth of the intracellular pathogen Leishmania. They are thus generally considered as likely candidates for the presentation of parasite Ag to CD4+ T lymphocytes known to be involved in protective and counterprotective immune responses. In the present study, we examined whether mouse macrophages infected with Leishmania were capable of stimulating T cell hybrids and a T cell clone reacting with the previously identified protective Ag LACK (Leishmania homologue of receptors for Activated C Kinase). This parasite protein is expressed in both promastigote and amastigote stages of Leishmania. We found that IFN-gamma-treated macrophages recently infected with live Leishmania promastigotes were fully competent to activate LACK-reactive T cells. However, at later times of infection, permissive macrophages infected with promastigotes were no longer able to present LACK, in spite of the presence of numerous intracellular parasites. This punctual presentation of LACK was apparently linked with the destruction, at least partial, of the intracellular parasites. In contrast, macrophages infected with live Leishmania amastigotes were always unable to stimulate the LACK-specific T cells. Amastigote-infected macrophages could, however, reactivate the T cells if LACK-delta(1), a recombinant form of LACK, was added as an exogenous protein in the culture medium. Similar results were obtained with all combinations tested involving macrophages from various origins, different activating cytokines (IFN- gamma, granulocyte-macrophage CSF, IL-4), several Leishmania species (L. amazonensis, L. major, L. donovani), and 15 different LACK-reactive T cell hybrids and clones. From these data, it is tempting to propose that the differentiation of promastigotes into amastigotes, which leads to a better survival of the parasites within macrophages, also allows them to go unnoticed by the immune system.

This article has been cited by other articles:

				A. Iwasaki The Importance of CD11b+ Dendritic Cells in CD4+ T Cell Activation In Vivo: With Help from Interleukin 1 J. Exp. Med., July 21, 2003; 198(2): 185 - 190. [Full Text] [PDF]

				T. Lang, N. Courret, J.-H. Colle, G. Milon, and J.-C. Antoine The Levels and Patterns of Cytokines Produced by CD4 T Lymphocytes of BALB/c Mice Infected with Leishmania major by Inoculation into the Ear Dermis Depend on the Infectiousness and Size of the Inoculum Infect. Immun., May 1, 2003; 71(5): 2674 - 2683. [Abstract] [Full Text] [PDF]

				D. Skokos, H. G. Botros, C. Demeure, J. Morin, R. Peronet, G. Birkenmeier, S. Boudaly, and S. Mecheri Mast Cell-Derived Exosomes Induce Phenotypic and Functional Maturation of Dendritic Cells and Elicit Specific Immune Responses In Vivo J. Immunol., March 15, 2003; 170(6): 3037 - 3045. [Abstract] [Full Text] [PDF]

				C. Berberich, J. R. Ramirez-Pineda, C. Hambrecht, G. Alber, Y. A. W. Skeiky, and H. Moll Dendritic Cell (DC)-Based Protection Against an Intracellular Pathogen Is Dependent Upon DC-Derived IL-12 and Can Be Induced by Molecularly Defined Antigens J. Immunol., March 15, 2003; 170(6): 3171 - 3179. [Abstract] [Full Text] [PDF]

				P. C. Melby, J. Yang, W. Zhao, L. E. Perez, and J. Cheng Leishmania donovani p36(LACK) DNA Vaccine Is Highly Immunogenic but Not Protective against Experimental Visceral Leishmaniasis Infect. Immun., August 1, 2001; 69(8): 4719 - 4725. [Abstract] [Full Text] [PDF]

				I. B. Kremer, M. P. Gould, K. D. Cooper, and F. P. Heinzel Pretreatment with Recombinant Flt3 Ligand Partially Protects against Progressive Cutaneous Leishmaniasis in Susceptible BALB/c Mice Infect. Immun., February 1, 2001; 69(2): 673 - 680. [Abstract] [Full Text] [PDF]

				F. A. Torrentera, N. Glaichenhaus, J. D. Laman, and Y. Carlier T-Cell Responses to Immunodominant LACK Antigen Do Not Play a Critical Role in Determining Susceptibility of BALB/c Mice to Leishmania mexicana Infect. Immun., January 1, 2001; 69(1): 617 - 621. [Abstract] [Full Text] [PDF]

				P. Probst, E. Stromberg, H. W. Ghalib, M. Mozel, R. Badaro, S. G. Reed, and J. R. Webb Identification and Characterization of T Cell-Stimulating Antigens from Leishmania by CD4 T Cell Expression Cloning J. Immunol., January 1, 2001; 166(1): 498 - 505. [Abstract] [Full Text] [PDF]

				N. Soussi, G. Milon, J.-H. Colle, E. Mougneau, N. Glaichenhaus, and P. L. Goossens Listeria monocytogenes as a Short-Lived Delivery System for the Induction of Type 1 Cell-Mediated Immunity against the p36/LACK Antigen of Leishmania major Infect. Immun., March 1, 2000; 68(3): 1498 - 1506. [Abstract] [Full Text] [PDF]

				A Cuvillier, F Redon, J. Antoine, P Chardin, T DeVos, and G Merlin LdARL-3A, a Leishmania promastigote-specific ADP-ribosylation factor-like protein, is essential for flagellum integrity J. Cell Sci., January 6, 2000; 113(11): 2065 - 2074. [Abstract] [PDF]

				J Alexander, A. Satoskar, and D. Russell Leishmania species: models of intracellular parasitism J. Cell Sci., January 9, 1999; 112(18): 2993 - 3002. [Abstract] [PDF]

				J. Antoine, T Lang, E Prina, N Courret, and R Hellio H-2M molecules, like MHC class II molecules, are targeted to parasitophorous vacuoles of Leishmania-infected macrophages and internalized by amastigotes of L. amazonensis and L. mexicana J. Cell Sci., January 8, 1999; 112(15): 2559 - 2570. [Abstract] [PDF]

				S. L. Reiner, D. J. Fowell, N. H. Moskowitz, K. Swier, D. R. Brown, C. R. Brown, C. W. Turck, P. A. Scott2, N. Killeen, and R. M. Locksley3 Control of Leishmania major by a Monoclonal {alpha}{beta} T Cell Repertoire J. Immunol., January 15, 1998; 160(2): 884 - 889. [Abstract] [Full Text] [PDF]